Literature DB >> 29109143

MicroRNA-874-mediated inhibition of the major G1/S phase cyclin, CCNE1, is lost in osteosarcomas.

Tanushree Ghosh1, Akhil Varshney1, Praveen Kumar1, Manpreet Kaur1, Vipin Kumar1, Ritu Shekhar1, Raksha Devi1, Priyanka Priyanka1, Md Muntaz Khan1, Sandeep Saxena2.   

Abstract

The tumor microenvironment is characterized by nutrient-deprived conditions in which the cancer cells have to adapt for survival. Serum starvation resembles the growth factor deprivation characteristic of the poorly vascularized tumor microenvironment and has aided in the discovery of key growth regulatory genes and microRNAs (miRNAs) that have a role in the oncogenic transformation. We report here that miR-874 down-regulates the major G1/S phase cyclin, cyclin E1 (CCNE1), during serum starvation. Because the adaptation of cancer cells to the tumor microenvironment is vital for subsequent oncogenesis, we tested for miR-874 and CCNE1 interdependence in osteosarcoma cells. We observed that miR-874 inhibits CCNE1 expression in primary osteoblasts, but in aggressive osteosarcomas, miR-874 is down-regulated, leading to elevated CCNE1 expression and appearance of cancer-associated phenotypes. We established that loss of miR-874-mediated control of cyclin E1 is a general feature of osteosarcomas. The down-regulation of CCNE1 by miR-874 is independent of E2F transcription factors. Restoration of miR-874 expression impeded S phase progression, suppressing aggressive growth phenotypes, such as cell invasion, migration, and xenograft tumors, in nude mice. In summary, we report that miR-874 inhibits CCNE1 expression during growth factor deprivation and that miR-874 down-regulation in osteosarcomas leads to CCNE1 up-regulation and more aggressive growth phenotypes.
© 2017 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  cancer biology; cell biology; cell cycle; cell proliferation; cyclin; cyclin E1; microRNA (miRNA); microRNA mechanism; non-coding RNA; oncogenesis

Mesh:

Substances:

Year:  2017        PMID: 29109143      PMCID: PMC5766939          DOI: 10.1074/jbc.M117.808287

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  47 in total

1.  Human interferon: mass production in a newly established cell line, MG-63.

Authors:  A Billiau; V G Edy; H Heremans; J Van Damme; J Desmyter; J A Georgiades; P De Somer
Journal:  Antimicrob Agents Chemother       Date:  1977-07       Impact factor: 5.191

2.  MicroRNA-874 inhibits cell proliferation and induces apoptosis in human breast cancer by targeting CDK9.

Authors:  Ling Wang; Wen Gao; Fan Hu; Zhiyang Xu; Fuqiang Wang
Journal:  FEBS Lett       Date:  2014-10-02       Impact factor: 4.124

3.  miR-132 targeting cyclin E1 suppresses cell proliferation in osteosarcoma cells.

Authors:  Jin Wang; Guoxing Xu; Feng Shen; Yifan Kang
Journal:  Tumour Biol       Date:  2014-01-22

4.  Cultivation in vitro of cells derived from a human osteosarcoma.

Authors:  R M McAllister; M B Gardner; A E Greene; C Bradt; W W Nichols; B H Landing
Journal:  Cancer       Date:  1971-02       Impact factor: 6.860

5.  Cyclin: a protein specified by maternal mRNA in sea urchin eggs that is destroyed at each cleavage division.

Authors:  T Evans; E T Rosenthal; J Youngblom; D Distel; T Hunt
Journal:  Cell       Date:  1983-06       Impact factor: 41.582

6.  Cyclin E1 is amplified and overexpressed in osteosarcoma.

Authors:  William W Lockwood; Deirdre Stack; Thomas Morris; David Grehan; Conor O'Keane; Greg L Stewart; Joanna Cumiskey; Wan L Lam; Jeremy A Squire; David M Thomas; Maureen J O'Sullivan
Journal:  J Mol Diagn       Date:  2011-03-31       Impact factor: 5.568

7.  Down-regulation of the cyclin E1 oncogene expression by microRNA-16-1 induces cell cycle arrest in human cancer cells.

Authors:  Fu Wang; Xiang-Dong Fu; Yu Zhou; Yi Zhang
Journal:  BMB Rep       Date:  2009-11-30       Impact factor: 4.778

8.  Cyclin E correlates with malignancy and adverse prognosis in adrenocortical tumors.

Authors:  Frédérique Tissier; Albert Louvel; Sophie Grabar; Anne-Marie Hagnéré; Jérôme Bertherat; Marie-Cécile Vacher-Lavenu; Bertrand Dousset; Yves Chapuis; Xavier Bertagna; Christine Gicquel
Journal:  Eur J Endocrinol       Date:  2004-06       Impact factor: 6.664

9.  Specific and sensitive quantitative RT-PCR of miRNAs with DNA primers.

Authors:  Ingrid Balcells; Susanna Cirera; Peter K Busk
Journal:  BMC Biotechnol       Date:  2011-06-25       Impact factor: 2.563

10.  Human fibroblast switches to anaerobic metabolic pathway in response to serum starvation: a mimic of warburg effect.

Authors:  Monireh Golpour; Haleh Akhavan Niaki; Hamid Reza Khorasani; Arian Hajian; Roya Mehrasa; Amrollah Mostafazadeh
Journal:  Int J Mol Cell Med       Date:  2014
View more
  15 in total

Review 1.  miRNA signatures in childhood sarcomas and their clinical implications.

Authors:  G M Viera; K B Salomao; G R de Sousa; M Baroni; L E A Delsin; J A Pezuk; M S Brassesco
Journal:  Clin Transl Oncol       Date:  2019-04-04       Impact factor: 3.405

2.  The microRNAs miR-449a and miR-424 suppress osteosarcoma by targeting cyclin A2 expression.

Authors:  Ritu Shekhar; Priyanka Priyanka; Praveen Kumar; Tanushree Ghosh; Md Muntaz Khan; Perumal Nagarajan; Sandeep Saxena
Journal:  J Biol Chem       Date:  2019-01-24       Impact factor: 5.157

3.  Down-regulation of CCNE1 expression suppresses cell proliferation and sensitizes gastric carcinoma cells to Cisplatin.

Authors:  Chao Zhang; Qiang Zhu; Jianzhong Gu; Shan Chen; Qian Li; Liping Ying
Journal:  Biosci Rep       Date:  2019-06-04       Impact factor: 3.840

4.  Role of miRNA-542-5p in the tumorigenesis of osteosarcoma.

Authors:  Tengjiao Zhu; Daoyang Fan; Kaifeng Ye; Bingchuan Liu; Zhiyong Cui; Zhongjun Liu; Yun Tian
Journal:  FEBS Open Bio       Date:  2020-03-18       Impact factor: 2.693

5.  MicroRNA-340-5p inhibits colon cancer cell migration via targeting of RhoA.

Authors:  Anwar Algaber; Amr Al-Haidari; Raed Madhi; Milladur Rahman; Ingvar Syk; Henrik Thorlacius
Journal:  Sci Rep       Date:  2020-10-09       Impact factor: 4.379

6.  Differential expression of circulating serum miR-1249-3p, miR-3195, and miR-3692-3p in non-small cell lung cancer.

Authors:  Sachin Kumar; Surender K Sharawat; Ashraf Ali; Vikas Gaur; Prabhat Singh Malik; Monu Pandey; Sunil Kumar; Anant Mohan; Randeep Guleria
Journal:  Hum Cell       Date:  2020-03-25       Impact factor: 4.174

7.  Targeting FHL2-E-cadherin axis by miR-340-5p attenuates colon cancer cell migration and invasion.

Authors:  Anwar Algaber; Raed Madhi; Avin Hawez; Carl-Fredrik Rönnow; Milladur Rahman
Journal:  Oncol Lett       Date:  2021-07-03       Impact factor: 2.967

8.  Expression of microRNA-99a-3p in Prostate Cancer Based on Bioinformatics Data and Meta-Analysis of a Literature Review of 965 Cases.

Authors:  Hai-Biao Yan; Yu Zhang; Jie-Mei Cen; Xiao Wang; Bin-Liang Gan; Jia-Cheng Huang; Jia-Yi Li; Qian-Hui Song; Sheng-Hua Li; Gang Chen
Journal:  Med Sci Monit       Date:  2018-07-12

9.  Influence of gene expression on survival of clear cell renal cell carcinoma.

Authors:  Anders Berglund; Ernest K Amankwah; Young-Chul Kim; Philippe E Spiess; Wade J Sexton; Brandon Manley; Hyun Y Park; Liang Wang; Jad Chahoud; Ratna Chakrabarti; Chang D Yeo; Hung N Luu; Giuliano D Pietro; Alexander Parker; Jong Y Park
Journal:  Cancer Med       Date:  2020-09-28       Impact factor: 4.452

10.  SNP-SNP interactions of oncogenic long non-coding RNAs HOTAIR and HOTTIP on gastric cancer susceptibility.

Authors:  Esmat Abdi; Saeid Latifi-Navid; Saber Zahri; Vahid Kholghi-Oskooei; Behdad Mostafaiy; Abbas Yazdanbod; Farhad Pourfarzi
Journal:  Sci Rep       Date:  2020-10-07       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.